Fischer Medical Ventures Limited
NSE: FISCHER · Medical Equipment & Supplies
Snapshot
Unlock Fischer Medical Ventures Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Fischer Medical Ventures Limited is a medical technology company that manufactures, distributes, and maintains a diverse range of diagnostic and healthcare equipment. Its portfolio spans advanced imaging systems like MRI and CT scanners, preventive health kiosks, and various e-health and screening solutions.
Business Model
The company generates revenue through the direct sale, leasing, and long-term maintenance of medical equipment and diagnostic devices. It serves both domestic and international markets with a focus on integrated healthcare technology solutions.
- Incorporation Year:1993
Management Commentary
Management has recently pivoted the company's strategic focus toward medical ventures, evidenced by the corporate name change from Fischer Chemic Limited in March 2024.
Growth Outlook
Growth is expected to be driven by the expansion of its diagnostic product portfolio and the increasing demand for preventive healthcare and e-health infrastructure in India.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory requirements for medical device manufacturing and distribution across different international jurisdictions.
- Technological Obsolescence. Rapid advancements in medical imaging and diagnostic technology require continuous investment in research and development to remain competitive.
- Market Competition. The medical equipment sector is highly competitive, with established global players exerting significant pressure on pricing and market share.
- Supply Chain Dependencies. Reliance on global supply chains for critical components and raw materials exposes the company to geopolitical and logistical disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Fischer Medical Ventures Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹367 Cr
TTM · consolidated
NET PROFIT
₹30 Cr
TTM · consolidated
EPS
₹2.40
TTM · consolidated
RETURN ON EQUITY
7.7%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
12.8%
TTM · consolidated
P/E
13.9×
Q1 FY27 · consolidated
EV/EBITDA
41.3x
Q1 FY27 · consolidated
EBITDA MARGIN
15.4%
TTM · consolidated
NET PROFIT MARGIN
4.6%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.2x
Q1 FY27 · consolidated
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Fischer Medical Ventures LimitedFISCHER | ₹2,272 Cr | 13.9× | 41.34 | 196.0% | 15.4% | 7.7% | 12.8% | -68.9% |
Tarsons ProductsTARSONS | ₹1,785 Cr | 157.6× | 14.68 | 10.6% | 33.1% | 1.8% | 4.5% | +6.6% |
Laxmi DentalLAXMIDENTL | ₹1,072 Cr | 34.3× | 19.35 | — | 19.2% | 13.7% | 13.3% | -40.8% |
Hemant Surgical Industries LimitedHSIL | ₹894 Cr | — | — | — | 10.0% | — | — | +91.5% |
Vasa Denticity LimitedDENTALKART | ₹718 Cr | — | — | — | 4.2% | — | — | -24.1% |
Prevest DenproPREVEST | ₹461 Cr | — | — | — | 36.0% | — | — | -31.1% |
As of Q1 FY27
Financials
Fischer Medical Ventures Limited
NSE: FISCHER · Medical Equipment & Supplies
Snapshot
Unlock Fischer Medical Ventures Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Fischer Medical Ventures Limited is a medical technology company that manufactures, distributes, and maintains a diverse range of diagnostic and healthcare equipment. Its portfolio spans advanced imaging systems like MRI and CT scanners, preventive health kiosks, and various e-health and screening solutions.
Business Model
The company generates revenue through the direct sale, leasing, and long-term maintenance of medical equipment and diagnostic devices. It serves both domestic and international markets with a focus on integrated healthcare technology solutions.
- Incorporation Year:1993
Management Commentary
Management has recently pivoted the company's strategic focus toward medical ventures, evidenced by the corporate name change from Fischer Chemic Limited in March 2024.
Growth Outlook
Growth is expected to be driven by the expansion of its diagnostic product portfolio and the increasing demand for preventive healthcare and e-health infrastructure in India.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory requirements for medical device manufacturing and distribution across different international jurisdictions.
- Technological Obsolescence. Rapid advancements in medical imaging and diagnostic technology require continuous investment in research and development to remain competitive.
- Market Competition. The medical equipment sector is highly competitive, with established global players exerting significant pressure on pricing and market share.
- Supply Chain Dependencies. Reliance on global supply chains for critical components and raw materials exposes the company to geopolitical and logistical disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Fischer Medical Ventures Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹367 Cr
TTM · consolidated
NET PROFIT
₹30 Cr
TTM · consolidated
EPS
₹2.40
TTM · consolidated
RETURN ON EQUITY
7.7%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
12.8%
TTM · consolidated
P/E
13.9x
Q1 FY27 · consolidated
EV/EBITDA
41.3x
Q1 FY27 · consolidated
EBITDA MARGIN
15.4%
TTM · consolidated
NET PROFIT MARGIN
4.6%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.2x
Q1 FY27 · consolidated
Peers · Medical Equipment & Supplies
As of Q1 FY27